Literature DB >> 10558920

4-Hydroxynonenal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: immunochemical detection and lobular localization.

D P Hartley1, K L Kolaja, J Reichard, D R Petersen.   

Abstract

The metabolism of CCl(4) initiates the peroxidation of polyunsaturated fatty acids producing alpha,beta-unsaturated aldehydes, such as 4-hydroxynonenal (4-HNE) and malondialdehyde (MDA). The facile reactivity of these electrophilic aldehydic products suggests they play a role in the toxicity of compounds like CCl(4). To determine the rate at which CCl(4)-initiated lipid peroxidation results in the formation of 4-HNE and/or MDA hepatic protein adducts, rats were given an intragastric dose of CCl(4) (1.0 ml/kg) and euthanized 0-72 h after administration. Rabbit polyclonal antisera directed toward 4-HNE- or MDA-protein epitopes were employed in immuno-histochemical and immuno-precipitation/Western analyses to detect 4-HNE and MDA-protein adducts in paraffin-embedded liver sections and liver homogenates. As early as 6 h post CCl(4) exposure, 4-HNE and MDA adducts were detected immuno-histochemically in hepatocytes localized to zone 2 of the hepatic acinus. Liver injury was progressive to 24 h as lipid peroxidation and hepatocellular necrosis increased. The hallmark of CCl(4) hepatotoxicity, zone 3 necrosis, was observed 24 h after CCl(4) administration and immuno-positive hepatocytes were observed in zone 2 as well as zone 3. Immuno-positive cells were no longer visible by 36 to 72 h post CCl(4) administration. From 6 to 48 h after CCl(4) administration, at least four adducted proteins were immuno-precipitated from liver homogenates with the anti-MDA or anti-4HNE serum, which corresponded to molecular weights of 80, 150, 205, and greater than 205 kDa. These results demonstrate that 4-HNE and MDA alkylate specific hepatic proteins in a time-dependent manner, which appears to be associated with hepatocellular injury following CCl(4) exposure. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10558920     DOI: 10.1006/taap.1999.8788

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  27 in total

1.  Urinary oxidative stress markers in children with autism.

Authors:  Lakshmi Priya Malarveni Damodaran; Geetha Arumugam
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

2.  Metabolic and proteomic markers for oxidative stress. New tools for reactive oxygen species research.

Authors:  Vladimir Shulaev; David J Oliver
Journal:  Plant Physiol       Date:  2006-06       Impact factor: 8.340

3.  Toll-like receptor 4 blocker as potential therapy for acetaminophen-induced organ failure in mice.

Authors:  Mohamed Salama; Mohamed Elgamal; Azza Abdelaziz; Moataz Ellithy; Dina Magdy; Lina Ali; Emad Fekry; Zinab Mohsen; Mariam Mostafa; Hoda Elgamal; Hussein Sheashaa; Mohamed Sobh
Journal:  Exp Ther Med       Date:  2015-04-22       Impact factor: 2.447

4.  Protective effect of probucol on liver injury induced by carbon tetrachloride in rats.

Authors:  Yu-Tao Zhan; Jing Weng; Li Li; Qing Xu; Xin Song; Xiao-Xia Guo
Journal:  Hepatol Int       Date:  2011-02-10       Impact factor: 6.047

5.  The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).

Authors:  Jeffrey D Coleman; K Sandeep Prabhu; Jerry T Thompson; P Sreenivasula Reddy; Jeffrey M Peters; Blake R Peterson; C Channa Reddy; John P Vanden Heuvel
Journal:  Free Radic Biol Med       Date:  2007-01-08       Impact factor: 7.376

Review 6.  Redox Signaling by Reactive Electrophiles and Oxidants.

Authors:  Saba Parvez; Marcus J C Long; Jesse R Poganik; Yimon Aye
Journal:  Chem Rev       Date:  2018-08-27       Impact factor: 60.622

7.  Susceptibility of L-FABP-/- mice to oxidative stress in early-stage alcoholic liver.

Authors:  Rebecca L Smathers; James J Galligan; Colin T Shearn; Kristofer S Fritz; Kelly Mercer; Martin Ronis; David J Orlicky; Nicholas O Davidson; Dennis R Petersen
Journal:  J Lipid Res       Date:  2013-01-28       Impact factor: 5.922

8.  Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives.

Authors:  Andrew Vila; Keri A Tallman; Aaron T Jacobs; Daniel C Liebler; Ned A Porter; Lawrence J Marnett
Journal:  Chem Res Toxicol       Date:  2008-01-31       Impact factor: 3.739

9.  4-Hydroxynonenal induces G2/M phase cell cycle arrest by activation of the ataxia telangiectasia mutated and Rad3-related protein (ATR)/checkpoint kinase 1 (Chk1) signaling pathway.

Authors:  Pankaj Chaudhary; Rajendra Sharma; Mukesh Sahu; Jamboor K Vishwanatha; Sanjay Awasthi; Yogesh C Awasthi
Journal:  J Biol Chem       Date:  2013-06-03       Impact factor: 5.157

10.  Immunohistochemical characterization of hepatic malondialdehyde and 4-hydroxynonenal modified proteins during early stages of ethanol-induced liver injury.

Authors:  Brante P Sampey; Soheila Korourian; Martin J Ronis; Thomas M Badger; Dennis R Petersen
Journal:  Alcohol Clin Exp Res       Date:  2003-06       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.